01-Dec-2014 03:28 PM
Proteome Sciences has confirmed that James Malthouse has, as announced on 30 September, retired today as a director and as company secretary.
Finance director Geoffrey Ellis has been appointed as company secretary.
At 3:28pm: (LON:PRM) Proteome Science
12-Nov-2014 09:21 AM
Proteome Sciences said anticipated contract delays means revenue for the current year will be lower than market expectations and somewhat lower than the revenues achieved in 2013.
The delayed revenues were expected to be booked in 2015, supported by str
25-Sep-2014 10:24 AM
Proteome Sciences has signed a $2m contract with Genting TauRx Diagnostic Centre to develop diagnostic panels to detect Alzheimer's disease and monitor treatment efficacy.
Its PS Biomarker Services Division ("PS") has been selected to deve
07-Feb-2014 07:23 AM
Proteome Sciences said revenue for 2013 is expected be significantly higher than in 2012 due to the strong performances across its core activities.
"The Orbitrap Fusion mass spectrometer provided as part of the licensing deal with Thermo Fisher Sci
04-Dec-2013 07:30 AM
Proteome Sciences sales lead times however have taken longer than anticipated and the timing and revenue from a number of other contracts expected in the fourth quarter has been delayed and is now projected to fall into 2014.
"Our pipeline and the
30-Sep-2013 08:56 AM
Proteome Sciences' H1 pretax loss widened to £1.9m, from a loss of £1.7m. Total revenue was £0.89m, from £0.81m. "Our core activities are performing well and we hope to show a considerable increase in revenue for the full year with that perf
18-Sep-2013 02:17 PM
Proteome Sciences presented novel data and key assay developments at the HUPO 12th Annual World Congress in Japan.
The data covered Tau in Alzheimer's disease, SysQuant in pancreatic cancer and a missing isoform in sugar structures of clusterin, a p
06-Aug-2013 12:41 PM
Proteome Sciences has received a direct approach from an institutional investor to subscribe for 3,750,000 new ordinary shares at a price of 41.5p per share.
The issue raised approximately £1.57m which will be used as additional working capital to dev
28-Jun-2013 01:08 PM
Proteome Sciences expects a sharp increase in group revenue in 2013, the company's annual general meeting statement says.
The group says its commercial activities are benefiting from its technology development and the rapid increase in the numbers
12-Jun-2013 07:19 AM
Proteome Sciences has confirmed its largest contract to date, a technology agreement with Thermo Fisher Scientific, valued at $2.1million by Proteome Sciences, to develop advanced methods to profile changes in key cancer pathways.
Proteome Sciences woul
30-May-2013 07:50 AM
Preteome Sciences widened its full-year pretax loss to £5.2 million, from £4.5 million. Revenue was £1.2 million, from £1.0 million.
"Protein biomarkers are receiving increasing prominence and attention and we are benefiting from a broad and gro
22-Jan-2013 08:28 AM
Proteome Sciences said in a trading statement that it expects strong revenue growth across its three main divisions in 2013, but that its full-year results will be dented by a contract delay.
and looks to the future with confidence.
The company said it
20-Aug-2012 08:16 AM
Proteome Sciences has announced it will collaborate with CHDI Foundation, Inc. on a systems biology project regarding Huntington's disease.
Initially, Proteome will provide its PS Biomarker Services�?¢ protein profiling to CHDI's research
05-Apr-2012 08:16 AM
Proteome Sciences has today granted a non-exclusive licence to Randox Laboratories for its portfolio of stroke biomarkers.
Under the terms of the agreement Randox will develop products for early diagnosis of stroke and subsequent monitoring of treatment
22-Dec-2011 09:33 AM
Proteome Sciences has confirmed that selected compounds, previously identified as potential inhibitors against CK1δ, have now been tested in cells and have shown strong activity.
Further IP has been filed to cover the results which the Directors believ
26-Jul-2011 08:46 AM
Proteome Sciences has appointed Glenn Barney as VP Business Development in North America.
Prior to joining the Proteome Sciences team, Barney was the VP Business Development for NextGen Sciences Inc. and was responsible for the commercialization of a s
07-Jul-2011 08:37 AM
Proteome Sciences plc a global leader in applied proteomics has entered into a collaboration agreement with Moffitt Cancer Center.
Under the agreement, Proteome will support research to develop mass spectrometry assays measuring certain key signalling an
27-May-2011 09:17 AM
Proteome Sciences has reported a strong swing back to profits after the receipt of Euro 11m following the settlement of a warranty claim against Sanofi-Aventis.
Pre-tax profits for the year to 31 December 2010, including the Euro 11m receipt, were £4.
20-Dec-2010 11:22 AM
Proteome Sciences plc has signed a research contract with Belgium's Janssen Pharmaceutica NV, part of the Johnson & Johnson group.
PS Biomarker Services will use a combination of its proprietary TMT isobaric mass tag technology, sample preparation
30-Nov-2010 12:11 PM
Research group Proteome Sciences plc said it was unlikely to make a pre-tax profit in 2010 because of contract delays but expected to report a profit before exceptionals following a successful warranty claim against Sanofi-Aventis.
The group had previous
28-Sep-2010 12:06 PM
Biotech R&D company Proteome Sciences will receive €11m tomorrow (September 29) following settlement of a dispute with Sanofi-Aventis dating back to 2002.
Proteome Sciences filed a court claim for breach of contractual and statutory obligations by
23-Sep-2010 12:30 PM
Proteome Sciences announced an additional collaboration with Thermo Fisher Scientific Inc. to deliver innovative products in protein biomarker research and further develop quantitative proteomic workflows for biomarker discovery and validation.
18-Jun-2010 09:46 AM
Research and development company Proteome Sciences has been notified by the Higher Regional Court in Frankfurt that it intends to take witness evidence at the end of July in connection with the company's warranty claim against Sanofi.
11-Jun-2010 09:35 AM
Proteome Sciences has circulated shareholders with details of its proposed placing to raise £4.81m and open offer to raise up to £2.06m more.
The open offer is being made on a pre-emptive basis, allowing all qualifying shareholders to participate. The p
07-Jun-2010 04:32 PM
Proteome Sciences posts a pre-tax loss of £4.2m for the year to the end of December compared with £4.8m in 2008.
Revenues rose to £1.3m - up from £849,487 - and gross profits increased to £976,694 from £623,613.
The group had cash and cash equivalents o